Tau protects microtubules in the axon from severing by katanin

Drexel University, Filadelfia, Pennsylvania, United States
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience (Impact Factor: 6.34). 04/2006; 26(12):3120-9. DOI: 10.1523/JNEUROSCI.5392-05.2006
Source: PubMed


Microtubules in the axon are more resistant to severing by katanin than microtubules elsewhere in the neuron. We have hypothesized that this is because of the presence of tau on axonal microtubules. When katanin is overexpressed in fibroblasts, the microtubules are severed into short pieces, but this phenomenon is suppressed by the coexpression of tau. Protection against severing is also afforded by microtubule-associated protein 2 (MAP2), which has a tau-like microtubule-binding domain, but not by MAP1b, which has a different microtubule-binding domain. The microtubule-binding domain of tau is required for the protection, but within itself, provides less protection than the entire molecule. When tau (but not MAP2 or MAP1b) is experimentally depleted from neurons, the microtubules in the axon lose their characteristic resistance to katanin. These results, which validate our hypothesis, also suggest a potential explanation for why axonal microtubules deteriorate in neuropathies involving the dissociation of tau from the microtubules.

Download full-text


Available from: Athena Andreadis, Jul 24, 2014
  • Source
    • "In cell culture, tau colocalizes with the most dynamic microtubules [9], those showing the highest basal turnover rate among microtubule populations [34]. Moreover, siRNA-mediated knockdown of tau does not impair microtubule polymerization [35]. In addition, tau, via its MBD, interacts with other proteins such as actin [36], presenilin-1 (PS-1) [37], tau phosphatases [38], RNA [39], and DNA [40], strongly suggesting that tau has multiple functions apart from its putative role as modulator of microtubule dynamics. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Hyperphosphorylation and aggregation of the microtubule-associated protein tau in brain, are pathological hallmarks of a large family of neurodegenerative disorders, named tauopathies, which include Alzheimer’s disease. It has been shown that increased phosphorylation of tau destabilizes tau-microtubule interactions, leading to microtubule instability, transport defects along microtubules, and ultimately neuronal death. However, although mutations of the MAPT gene have been detected in familial early-onset tauopathies, causative events in the more frequent sporadic late-onset forms and relationships between tau hyperphosphorylation and neurodegeneration remain largely elusive. Oxidative stress is a further pathological hallmark of tauopathies, but its precise role in the disease process is poorly understood. Another open question is the source of reactive oxygen species, which induce oxidative stress in brain neurons. Mitochondria have been classically viewed as a major source for oxidative stress, but microglial cells were recently identified as reactive oxygen species producers in tauopathies. Here we review the complex relationships between tau pathology and oxidative stress, placing emphasis on (i) tau protein function, (ii) origin and consequences of reactive oxygen species production, and (iii) links between tau phosphorylation and oxidative stress. Further, we go on to discuss the hypothesis that tau hyperphosphorylation and oxidative stress are two key components of a vicious circle, crucial in neurodegenerative tauopathies.
    Full-text · Article · Nov 2015 · Oxidative medicine and cellular longevity
  • Source
    • "In addition, Shot binds along MT shafts and stabilises them independent of its linkage to F-actin (Sánchez-Soriano et al., 2009; Alves-Silva et al., 2012). Other MT shaft binders are Tau which protects MTs against the MT-severing protein Katanin in axons (not shown; Qiang et al., 2006), and mammalian MAP1B can cross-link MTs as well as mediate actin-MT linkage during axon growth (Bouquet et al., 2007; Riederer, 2007). Tau, MAP1B and Shot (in an EB1-independent mode) influence MT polymerisation kinetics through yet unknown mechanisms (stippled grey arrow; Alves-Silva et al., 2012; Feinstein and Wilson, 2005; Tymanskyj et al., 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The extension of long slender axons is a key process of neuronal circuit formation, both during brain development and regeneration. For this, growth cones at the tips of axons are guided towards their correct target cells by signals. Growth cone behaviour downstream of these signals is implemented by their actin and microtubule cytoskeleton. In the first part of this Commentary, we discuss the fundamental roles of the cytoskeleton during axon growth. We present the various classes of actin- and microtubule-binding proteins that regulate the cytoskeleton, and highlight the important gaps in our understanding of how these proteins functionally integrate into the complex machinery that implements growth cone behaviour. Deciphering such machinery requires multidisciplinary approaches, including genetics and the use of simple model organisms. In the second part of this Commentary, we discuss how the application of combinatorial genetics in the versatile genetic model organism Drosophila melanogaster has started to contribute to the understanding of actin and microtubule regulation during axon growth. Using the example of dystonin-linked neuron degeneration, we explain how knowledge acquired by studying axonal growth in flies can also deliver new understanding in other aspects of neuron biology, such as axon maintenance in higher animals and humans.
    Full-text · Article · May 2013 · Journal of Cell Science
  • Source
    • "As mentioned earlier, despite these seemingly critical functions of tau, tau knockout mice are viable, fertile, and relatively normal, with no signs of neurodegeneration. Furthermore, knockdown of tau with siRNA does not kill primary neurons in culture or prevent axon formation [61]. Thus, tau is not essential to neurons or to microtubules, likely due to compensation by and/or redundant functions of other proteins. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The abnormal deposition of proteins in and around neurons is a common pathological feature of many neurodegenerative diseases. Among these pathological proteins, the microtubule-associated protein tau forms intraneuronal filaments in a spectrum of neurological disorders. The discovery that dominant mutations in the MAPT gene encoding tau are associated with familial frontotemporal dementia strongly supports abnormal tau protein as directly involved in disease pathogenesis. This and other evidence suggest that tau is a worthwhile target for the prevention or treatment of tau-associated neurodegenerative diseases, collectively called tauopathies. However, it is critical to understand the normal biological roles of tau, the specific molecular events that induce tau to become neurotoxic, the biochemical nature of pathogenic tau, the means by which pathogenic tau exerts neurotoxicity, and how tau pathology propagates. Based on known differences between normal and abnormal tau, a number of approaches have been taken toward the discovery of potential therapeutics. Key questions still remain open, such as the nature of the connection between the amyloid- β protein of Alzheimer's disease and tau pathology. Answers to these questions should help better understand the nature of tauopathies and may also reveal new therapeutic targets and strategies.
    Full-text · Article · Dec 2012
Show more